Cargando…

Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus

BACKGROUND: Extended long‐term follow‐up data of new‐generation drug‐eluting stents in patients with diabetes mellitus is scant. The aim of this study is to assess the 10‐year clinical outcome of new‐generation biodegradable polymer‐based sirolimus‐eluting stents (Yukon Choice PC) versus permanent p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenz, Tobias, Koch, Tobias, Joner, Michael, Xhepa, Erion, Wiebe, Jens, Coughlan, J. J., Aytekin, Alp, Ibrahim, Tareq, Fusaro, Massimiliano, Cassese, Salvatore, Laugwitz, Karl‐Ludwig, Schunkert, Heribert, Kastrati, Adnan, Kufner, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477883/ https://www.ncbi.nlm.nih.gov/pubmed/34075784 http://dx.doi.org/10.1161/JAHA.120.020165

Ejemplares similares

Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus: Results of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial
por: Koch, Tobias, et al.
Publicado: (2021)

Target and non-target vessel related events at 10 years post percutaneous coronary intervention
por: Coughlan, J. J., et al.
Publicado: (2022)

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis
por: Nano, Nejva, et al.
Publicado: (2022)

Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range
por: Ndrepepa, Gjin, et al.
Publicado: (2023)

Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis
por: Wiebe, Jens, et al.
Publicado: (2021)

Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials
por: Pellegrini, Costanza, et al.
Publicado: (2020)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
por: Ott, Ilka, et al.
Publicado: (2017)

Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest – A propensity score-matched analysis
por: Lahmann, Anna Lena, et al.
Publicado: (2020)

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)

Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
por: Koch, Tobias, et al.
Publicado: (2023)

Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary Intervention
por: Rai, Himanshu, et al.
Publicado: (2022)

Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial
por: Harada, Yukinori, et al.
Publicado: (2016)

Histopathology-Based Deep-Learning Predicts Atherosclerotic Lesions in Intravascular Imaging
por: Holmberg, Olle, et al.
Publicado: (2021)

Comparison of latest generation supra-annular and intra-annular self-expanding transcatheter heart valves
por: Pellegrini, Costanza, et al.
Publicado: (2020)

Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial
por: Lahu, Shqipdona, et al.
Publicado: (2022)

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement
por: Lachmann, Mark, et al.
Publicado: (2022)

Frequency of subclavian artery stenosis in patients with mammarian artery coronary bypass and suspected coronary artery disease progression
por: Müller, Arne M., et al.
Publicado: (2022)

Harnessing feature extraction capacities from a pre-trained convolutional neural network (VGG-16) for the unsupervised distinction of aortic outflow velocity profiles in patients with severe aortic stenosis
por: Lachmann, Mark, et al.
Publicado: (2022)

Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
por: Behnes, Michael, et al.
Publicado: (2022)

Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells
por: Nicol, Philipp, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Asymptomatic Patients Hospitalized for Cardiac Emergencies: Implications for Patient Management
por: Kessler, Thorsten, et al.
Publicado: (2020)

Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial
por: Steppich, Birgit, et al.
Publicado: (2017)

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry
por: Mayer, Katharina, et al.
Publicado: (2023)

One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial
por: Rai, Himanshu, et al.
Publicado: (2021)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020)

Echocardiographic evaluation of left ventricular function using an automated analysis algorithm is feasible for beginners and experts: comparison with invasive and non-invasive methods
por: Nicol, Philipp, et al.
Publicado: (2022)

Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis
por: Lohaus, Raphaela, et al.
Publicado: (2016)

Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis
por: Ye, Yicong, et al.
Publicado: (2013)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
por: Lv, Jianfeng, et al.
Publicado: (2015)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction
por: Sager, Hendrik B., et al.
Publicado: (2019)

Machine Learning Identifies New Predictors on Restenosis Risk after Coronary Artery Stenting in 10,004 Patients with Surveillance Angiography
por: Güldener, Ulrich, et al.
Publicado: (2023)

Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis
por: Monjur, Mohammad Riashad, et al.
Publicado: (2020)

Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: a meta-analysis
por: Yuan, Haoyong, et al.
Publicado: (2022)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
por: Iglesias, Juan F., et al.
Publicado: (2019)

Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y(12) Inhibitor Thereafter
por: Lahu, Shqipdona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9apd3so6k0mvmpa8cs4oq18pp3